Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,937,700
-
Share change
-
+218,424
-
Total reported value
-
$2,437,394,440
-
Put/Call ratio
-
315%
-
Price per share
-
$67.82
-
Number of holders
-
217
-
Value change
-
+$36,673,100
-
Number of buys
-
104
-
Number of sells
-
134
Institutional Holders of GENOMIC HEALTH INC - COM (GHDX) as of Q3 2019
As of 30 Sep 2019,
GENOMIC HEALTH INC - COM (GHDX) was held by
217 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,937,700 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, ALPINE ASSOCIATES MANAGEMENT INC., Invesco Ltd., UBS Group AG, and Magnetar Financial LLC.
This page lists
217
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.